Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiac Allograft Vasculopathy”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Not applicableStudy completedNCT02077764
What this trial is testing

The GRAFT Study: Evaluation of Graft Function, Rejection and Cardiac Allograft Vasculopathy in First Heart Transplant Recipients.

Who this might be right for
Heart Transplant Recipients
Aarhus University Hospital Skejby 65
Not applicableStudy completedNCT05485467
What this trial is testing

The Role of CD34 + Stem Cells and Biomarkers in the Development of CAV in HTX Patients

Who this might be right for
VasculopathyHeart Transplant Failure
University Medical Centre Ljubljana 55
Not applicableWithdrawnNCT01305382
What this trial is testing

Noninvasive Evaluation of Cardiac Allograft Vasculopathy

Who this might be right for
Cardiac Allograft Vasculopathy
University of Minnesota
Post-approval studies (Phase 4)UnknownNCT02254668
What this trial is testing

Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography

Who this might be right for
Intimal ProliferationImmunosuppression
University of Zurich 278
Not applicableUnknownNCT01569334
What this trial is testing

Identification of Non Invasive Biomarkers of Immune Endothelial Injury and Repair Associated With Cardiac Allograft Vasculopathy

Who this might be right for
Cardiac Allograft Vasculopathy
Assistance Publique Hopitaux De Marseille 170
Not applicableLooking for participantsNCT06089486
What this trial is testing

MARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart Transplantation

Who this might be right for
Cardiac Allograft Vasculopathy
Ottawa Heart Institute Research Corporation 576
Not applicableWithdrawnNCT05756088
What this trial is testing

Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA

Who this might be right for
Cardiac Allograft VasculopathyEndothelial DysfunctionMicrovascular Coronary Artery Disease
Yale University
Not applicableStudy completedNCT04791852
What this trial is testing

Potential Role of Donor-derived Cell-Free DNA as a Biomarker in Cardiac Allograft Vasculopathy

Who this might be right for
Cardiac Allograft Vasculopathy
Puerta de Hierro University Hospital 94
Not applicableStudy completedNCT02347371
What this trial is testing

Heart Transplant Registry of Városmajor

Who this might be right for
Disorder Related to Cardiac Transplantation
Semmelweis University Heart and Vascular Center 11
Large-scale testing (Phase 3)Study completedNCT03734211
What this trial is testing

Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients

Who this might be right for
Cardiac Allograft Vasculopathy
Lars Gullestad 130
Large-scale testing (Phase 3)Active Not RecruitingNCT03386539
What this trial is testing

Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score

Who this might be right for
Pediatric Heart TransplantationImmunosuppressionChronic Kidney Diseases+4 more
Boston Children's Hospital 211
Post-approval studies (Phase 4)Study completedNCT02880137
What this trial is testing

Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy

Who this might be right for
Cardiac Allograft Vasculopathy
Mayo Clinic 36
Large-scale testing (Phase 3)WithdrawnNCT01157949
What this trial is testing

Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)

Who this might be right for
Cardiac Allograft Vasculopathy
Cedars-Sinai Medical Center
Not applicableStudy completedNCT01527344
What this trial is testing

Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography

Who this might be right for
Cardiac Allograft Vasculopathy
Mayo Clinic 82
Not applicableWithdrawnNCT01812434
What this trial is testing

Phosphodiesterase-5 (PDE-5) Inhibition in Heart Transplant Recipients

Who this might be right for
Cardiac Allograft Vasculopathy
University of Minnesota
Not applicableWithdrawnNCT01305395
What this trial is testing

Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients

Who this might be right for
Cardiac Allograft Vasculopathy
University of Minnesota
Large-scale testing (Phase 3)Ended earlyNCT01795729
What this trial is testing

Assessment of Revascularization Versus Conservative Treatment in Heart Transplant Patients for a Clinical Event Reduction

Who this might be right for
Heart-lung Transplant Rejection
Assistance Publique - Hôpitaux de Paris 6
Not applicableEnded earlyNCT01927614
What this trial is testing

Advanced Cardiac Imaging in Cardiac Allograft Vasculopathy

Who this might be right for
Heart Transplantation
Nova Scotia Health Authority 5
Not applicableLooking for participantsNCT05826444
What this trial is testing

Microvascular Cardiac Allograft Vasculopathy Trial

Who this might be right for
Cardiac Allograft Vasculopathy
German Heart Institute 50
Not applicableStudy completedNCT01386021
What this trial is testing

Saphenous Vein Allografts for Coronary Bypass

Who this might be right for
Coronary Artery DiseaseOcclusion of Artery
CryoLife, Inc. 1
Load More Results